Summary
For Year 2026-27, Astal Laboratories reports the following shareholding: Total Promoters at 18.19%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 81.81%. This breakdown provides a quick snapshot of ownership distribution for Astal Laboratories in 2026-27.
Astal Laboratories FAQs
As of 04-2026, the promoter shareholding in Astal Laboratories stands at 18.19% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Astal Laboratories is 0% and 0% respectively.
The retail shareholding of the Astal Laboratories is 81.81%.
Changes in shareholding patterns of Astal Laboratories can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Astal Laboratories are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
